1. Home
  2. BBNX vs WD Comparison

BBNX vs WD Comparison

Compare BBNX & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.91

Market Cap

997.9M

Sector

Health Care

ML Signal

HOLD

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$31.54

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBNX
WD
Founded
2015
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
997.9M
1.1B
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
BBNX
WD
Price
$16.91
$31.54
Analyst Decision
Buy
Buy
Analyst Count
15
4
Target Price
$24.24
★ $48.33
AVG Volume (30 Days)
★ 912.1K
530.8K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
★ 8.33%
EPS Growth
★ 78.95
N/A
EPS
N/A
★ 0.55
Revenue
$100,251,000.00
★ $1,234,306,000.00
Revenue This Year
$25.74
$9.25
Revenue Next Year
$44.51
$9.48
P/E Ratio
★ N/A
$59.36
Revenue Growth
★ 53.94
8.99
52 Week Low
$8.80
$31.40
52 Week High
$32.71
$90.00

Technical Indicators

Market Signals
Indicator
BBNX
WD
Relative Strength Index (RSI) 40.96 31.81
Support Level $15.76 N/A
Resistance Level $18.20 $52.37
Average True Range (ATR) 0.87 1.42
MACD -0.29 0.02
Stochastic Oscillator 24.84 6.77

Price Performance

Historical Comparison
BBNX
WD

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of its total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: